drug

metreleptin

1 story · latest Sep 29, 2026

Status: FDA approved Feb 2014 · BLA125390
Brand: Myalept
Trials: 1 registered trial in coverage

Relationships

Developed by Chiesi Farmaceutici

Timeline

Aquestive Therapeutics adds Rich Daly to board of directors

Sep 29PeopleAquestive Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.